智通财经APP获悉，亿胜生物科技(01061)盈警后跌近13%，截至发稿，跌12.89%，报2.5港元，报243.22万港元。
消息面上，7月17日，亿胜生物科技发布公告，本集团预期截至2026年6月30日止六个月(2026年中期期间)收益及溢利较本集团2025年同期收益约8.77亿港元及溢利约1.63亿港元分别减少约10%及30%，主要是由于中国实施新增值税法后本集团承担的增值税增加所致。
纵然存在上述情况，本集团仍维持稳健的现金流量及财务状况以满足其业务需求。于2026年6月30日，本集团的现金及现金等值物约为8.07亿港元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.